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ABSTRACT 
Approaches to remotely control and monitor ion channel operation with light are fast 
expanding in the field of biophysics and neuroscience. A recent development to directly 
introduce light-sensitivity into proteins relies on the genetic code expansion technique by 
utilizing photo-sensitive unnatural amino acids (UAAs). Introduction of UAAs results in unique 
molecular level control, and combined with the maximal spatio-temporal resolution and poor 
invasiveness of light, enables direct manipulation and interrogation of ion channel 
functionality. Here, we review the diverse applications of light-sensitive UAAs in two 
superfamilies of ion channels - voltage- and ligand-gated ion channels – and summarize the 
existing UAA tools, their mode of action, potential, caveats, and technical considerations to 
illuminate ion channel structure and function. 
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ION CHANNELS AS MEDIATORS OF ELECTRICAL SIGNALING 
All cells in the body – from epithelial, secretory, cardiac, neuronal, to muscle cells – contain 
ion channels. Amongst others, their activity mediates muscular contraction, vascular tone, 
electrical signaling in the heart as well as hormone secretion and cell proliferation. Ion 
channels also allow accurate brain function by controlling neuronal excitability and synaptic 
transmission [1]. Being large protein complexes embedded into biological membranes, ion 
channels do not only specify the functional properties of cells, but also of specific cellular 
sites and compartments. Electrical signaling across the membrane is shaped by controlled 
ion flow through their conducting pore, which is a remarkably precise and rapid biological 
event. 
 Ion channels are highly heterogeneous proteins on a structural and functional level. This 
heterogeneity is mostly mediated by their multimeric nature due to different combinations of 
subunits, creating a diversity of ion channel subtypes. Distinct subtypes can differ in their 
mode of activation, their conductive properties, and their pharmacological behavior. For 
example, GABAA receptors, a class of pentameric ion channels, can incorporate 16 different 
subunits, giving rise to at least 20 distinct subtypes in the brain with different biophysical and 
pharmacological properties [2]. Similarly, >10 subtypes of NMDA receptors (NMDARs), 
ionotropic glutamate receptors (iGluRs) that cluster at excitatory synapses, co-exist in the 
central nervous system [3]. This is even far outreached by potassium channels, whose 
subunits are encoded by no less than 77 genes, thus representing the most diverse ion 
channel class [4]. 
 Two ion channel superfamilies mediate a plethora of time-defined cellular processes: 
voltage-gated ion channels (VGICs) and ligand-gated ion channels (LGICs). VGICs are 
represented by a multiplicity of ion channel types, among others four-domain voltage-gated 
sodium and calcium channels, and one- or multi-domain channels such as voltage-gated 
potassium channels and channels from the transient receptor potential (TRP) family. 
Typically, all of those open their pore in dependence of changes in the membrane voltage, 
which is mediated by a voltage-sensing domain (VSD) [5, 6]. On the other hand, LGICs are 
activated by ligands that bind extra-cellular domains. They can be trimeric (such as P2X 
receptors), tetrameric (all iGluRs including AMPA, NMDA, and kainate receptors), or 
pentameric (e.g. GABAA and nicotinic acetylcholine receptors [nAChRs]) [7]. In addition to 
their gating core (i.e. the ion pore and the signal-sensing domains), most classes of ion 
channels contain accessory domains or are associated with auxiliary subunits, further 
diversifying their functional and signaling properties [8, 9].  
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 LGICs and VGICs are furthermore major potential drug targets, involved in a wide variety 
of pathologies and channelopathies [3, 7, 10]. Understanding in detail the complex gating 
and regulation processes of these channels in native conditions, where their subunit 
composition and microenvironment can influence their function, is key in drug design. So far, 
electrophysiology, molecular biology, biochemistry, pharmacology and structural biology (X-
ray crystallography and cryo-electron microscopy) have brought a wealth of information on 
these questions. However, these methods missed either structural, spatial, or temporal 
resolution, limiting our understanding of ion channel structure and function. Thus, methods 
with high spatial resolution and fast enough to synchronize with the channels’ dynamic mode 
of action during normal and disease states are required. 
 Light confers this required high spatio-temporal resolution. Various techniques such as 
fluorescence spectroscopy, ‘optopharmacology’ [11] and ‘optogenetic pharmacology’ (also 
coined ‘synthetic optogenetics’ [12]) exploit of the power of light, by engineering light-
responsiveness into ion channels and receptors (Table 1). Here, we review recent advances 
to directly introduce light-sensitivity into ion channels using genetically-encoded, photo-
receptive unnatural amino acids (UAAs). We discuss a group of light-sensitive UAAs, 
carrying different photo-chemical properties, and provide an overview of their implementation 
to address key questions regarding ion channel structure, gating, regulation, assembly, and 
physiology. By embedding the genetic UAA methodology into the large and fast growing field 
of molecular optogenetics, we highlight its strong potential, but also its limitations, and future 
perspectives in biomolecular engineering and cellular physiology. 
 
ENDOWING LIGHT-SENSITIVITY TO ION CHANNELS 
Traditional optogenetics has routinely utilized naturally occurring light-sensitive ion channels 
such as channelrhodopsins to study cellular activity by light. To address biological questions 
of endogenous, natively expressed ion channels, however, supplementary tools are required. 
For decades, conventional site-directed mutagenesis, pharmacological tools, or genetic 
manipulations (e.g. knock-out animals) have been the major techniques to provide direct 
functional information about ion channels. These have obvious limitations such as deficient 
molecular and cellular specificity, insufficient drug delivery, poor reversibility, or physiological 
compensatory effects. Above all, the development of subtype-specific pharmacological 
agents remains challenging, calling for novel approaches that allow precise molecular control 
over specific ion channel isoforms. 
 In close collaboration between biologists and chemists, various tools have been evolved 
to directly engineer light-responsiveness into ion channels, which are naturally non-receptive 
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 5 
to optical stimulation. Hereby, a distinction is drawn between the use of light-activatable 
ligands, acting specifically on an endogenous ion channel population (e.g. 4-GluAzo acting 
on iGluRs [13]; optopharmacology), and post-translational labeling approaches of genetically 
modified target ion channels (optogenetic pharmacology and fluorescence monitoring) [11, 
14-16] (Table 1). In the latter category, the powerful combination of optics, genetics, and 
pharmacology results in high molecular level control, which, combined with the unique 
properties of light, enables direct manipulation and interrogation of ion channel functionality. 
This allows to remotely investigate ion channel molecular operation and structural 
mechanisms, and provides means to photo-control their mode of action at the physiological 
level. 
 Currently, the leading strategy makes use of cysteine-mutated receptors labeled by 
tethered fluorophores or photo-sensitive tethered ligands (PTLs; Table 1). PTLs can 
comprise cysteine-tethered, photo-reactive compounds such as the benzophenone photo-
crosslinker BPMTS [17, 18] (Table 1). Most PTLs, however, are based on a photo-
isomerizable azobenzene moiety (see Glossary) that undergoes reversible toggling 
between two states upon exposure to light – a compact cis and a stretched trans 
configuration [19, 20]. PTLs also contain a cysteine-reactive group, usually a maleimide, and 
a pharmacologically active head group, which can turn on, turn off, or modulate channel 
activity (e.g. MAG [21]; Table 1). Since labeling is performed post-translationally, PTL 
functional loci are restricted to solvent accessible, extra-cellular protein sites [20]. Moreover, 
the resulting photo-control is limited at a certain maximum, never reaching completeness 
[22]. Although reducing agents may be applied to increase cysteine accessibility [11], the 
existence of mixed ion channel populations including labeled, light-sensitive, and unlabeled 
versions is inevitable. Finally, the turnover cycle of ion channels at cellular membranes 
requires cysteine re-labeling, when using PTLs [11]. PTL conjugation has been broadly 
applied in neuronal VGICs and LGICs to efficiently photo-control their activity [11, 12, 16, 20], 
and crucially, it has pioneered native ion channel photo-modulation in vivo [22-24]. 
 Recently, an attractive strategy to engineer light-responsiveness into ion channels hit the 
field of molecular optogenetics and became a powerful alternative to chemical labeling. It 
relies on the site-specific introduction of light-sensitive UAAs into ion channels by genetic 
code expansion to achieve optical control of their activity (Table 1). Below, we discuss the 
strong and fast expanding potential of these light-sensitive UAAs to study ion channels with 
excellent molecular and spatio-temporal precision, with a focus on important methodological 
aspects and the biological questions addressed so far.  
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INCORPORATING UAAs INTO ION CHANNELS 
The chemical composition of UAAs is broad including fluorescent, light-sensitive, redox-
active or bioconjugatable side-chains [25, 26]. Their distinctive feature is the ab initio 
introduction into the polypeptide sequence, just at the assigned time of its biosynthesis, thus 
not requiring any post-translational modifications. Combined with their minimal size of only 
one side-chain, UAAs are endowed with a theoretical ‘absolute‘ site tolerance [27]. This 
aspect is particularly important for ion channels, whose pore domain, embedded in the 
membrane bilayer, is largely solvent-inaccessible. Most channels further contain key 
regulatory intra-cellular domains that cannot be labeled post-translationally using the 
cysteine chemistry. The UAA methodology hijacks the translation machinery through the re-
assignment of a stop codon, which is, at present, the primary technique to site-specifically 
introduce UAAs. Traditionally, TAG ‘amber’ stop codons are used to be suppressed by a 
specific tRNA (the suppressor tRNA), aminoacylated with a UAA of interest [26, 28-30]. 
Sufficient amounts of the UAA within the cell are achieved by supplementing the compound 
into the cellular growth medium or directly injecting it into the cell. 
 UAA aminoacylation of tRNAs has first been carried out in vitro, followed by direct micro-
injection into Xenopus laevis oocytes, where the UAA is straight delivered onto the amber 
codon of a protein coding sequence [28, 31]. This way of protein manipulation requires the 
synthesis of the UAA followed by chemical tRNA aminoacylation in a test tube, offering a 
high-rate screening of UAAs and a high level of flexibility [28, 30]. Being however restricted 
to the application in large Xenopus oocytes, this chemical approach limits structural and 
functional ion channel studies that require more native cellular systems. Also, stoichiometric 
consumption and lack of in cellulo regeneration of the UAA-decorated tRNA, following 
cellular injection, limits the amount of the synthesized protein. 
 From the emerging demand to introduce UAAs into proteins expressed in mammalian 
cells, a more recent approach evolved, which relies on the genetic encoding of UAAs [26, 29, 
32] (Figure 1). This technique utilizes bio-orthogonal tRNA/synthetase pairs, specifically 
engineered for the introduction of a particular amino acid. All components required for 
‘nonsense’ stop codon suppression, including the amber version of the desired protein and 
the specific tRNA/synthetase pair, are introduced into the cell in the form of plasmids. Once 
processed within the cell, the tRNA is charged with the UAA by its cognate synthetase to 
suppress the amber codon on the protein mRNA. Bio-orthogonality and cellular compatibility 
of tRNA/synthetase pairs must accompany each other [26, 29, 32]. Thus, these pairs 
undergo longsome directed evolutionary processes in the lab, which can correspond to 
several years of work. Consequently, the genetic approach is overall slower and offers less 
flexibility compared to chemical UAA introduction. However, once evolved, this technique 
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 7 
greatly extends the possibilities of UAA utilization to a variety of systems, such as 
mammalian cell lines and neuronal cultures [33-35], brain slices [33, 36, 37], and even whole 
organisms including C. elegans [38], Drosophila [39], Zebrafish [40], and mice [33, 40, 41]. 
Beneficially, constant regeneration of the aminoacylated tRNA enables its repeated use 
within the cell (Figure 1) and thus high-scale protein yields. Compared to post-translational 
labeling with PTLs, usage of UAAs shares commonalities and differences that need to be 
carefully studied before deciding on the use on one or the other technique (Table 2). 
Furthermore, to overcome obstacles and facilitate the establishment of the UAA methodology 
in the lab, as well as to ensure its smooth implementation and an appropriate interpretation 
of the obtained data, a few major points are summarized in Box 1. 
 The following sections summarize recent advances in using light-sensitive and 
fluorescent UAAs to control and monitor diverse ion channel functionalities. Detailed 
technical and historical aspects of both the chemical and genetic UAA approach have been 
recently reviewed in detail elsewhere [29-31, 42]. 
 
TRACKING ION CHANNEL STRUCTURAL DYNAMICS USING FLUORESCENT UAAs 
(fUAAs) 
The capacity of fluorescent probes to undergo FRET or sense their direct chemical 
environment has been extensively used to monitor conformational changes of ion channels 
in real time. Moreover, when combined to electrical measurements as performed using VCF, 
it provides a unique correlation between structural rearrangements and gating steps 
(Figure 2A) [43]. Recently, fUAAs have proven to be powerful probes for FRET and VCF 
studies. 
 In a pioneering study, using nonsense suppression with in vitro aminoacylated tRNAs, 
Cohen et al. [44] introduced an alanine derivative of 6-dimethylamino-2-acyl-naphtalene 
(Aladan, Figure 2B) into buried sites of Shaker and Kir2.1 potassium channels. The 
Xenopus oocyte translation machinery is in fact capable of incorporating fluorophores as 
bulky as BODIPYFL [45], Cy3, and Cy5 into ion channels [46] (Figure 2B), suggesting that a 
wide variety of fUAAs can be potentially introduced into proteins using in vitro aminoacylated 
tRNAs. A few bio-orthogonal tRNA/synthetase pairs have also been developed for genetic 
encoding of fUAAs [25], such as small, naphthalene-derived fUAAs like (7-hydroxycoumarin-
4-yl)ethylglycine [47] and Dansyl-Alanine [48] (Figure 2C). (7-hydroxycoumarin-4-
yl)ethylglycine was incorporated at the pore entrance of NaK channels as a probe of ion 
selectivity [49]; Dansyl-Alanine, on the other hand, in the VSD of CiVSP, a voltage-
dependent enzyme containing a VSD similar to VGICs [50]. Interestingly, by introducing the 
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 8 
fluorophore at the external or internal extremity of the voltage-sensing helix S4, changes in 
cell membrane potential could be optically monitored. 
 A major leap forward in the field came with the recent development of 3-(6-
acetylnaphtalen-2-ylamino)-2-aminopropanoic acid (Anap, Figure 2C) [51, 52]. In regard of 
brightness and quantum yield, Anap is comparable to dansyl or coumarin fluorophores, 
however it displays strongly enhanced environmental sensitivity [52]. Anap is also a good 
FRET donor to GFP [53] or to transition metal ions [54-56], thus representing a powerful 
probe of protein conformational changes. It was first introduced in the VSD of Shaker [57], 
whose gating mechanisms have been thoroughly studied by VCF (reviewed in ref [58]). By 
introducing either Anap or a cysteine, labeled with tetramethylrhodamine maleimide (TMR), 
at the same S4 helix site, Anap appeared equally potent as TMR to track the voltage-sensing 
steps, but also reported additional conformational changes occurring at highly hyperpolarized 
potentials. Simultaneous motion tracking at both extremities of the critical S4 helix was even 
achieved by orthogonally inserting the two fluorophores at sites opposite to the membrane, 
Anap close to S4 intra-cellular end and TMR at the extra-cellular end (Figure 2D), something 
rather challenging using post-translational labeling only. The observed asynchronous 
fluorescence changes at the two S4 ends suggest different intra- and extra-cellular 
conformational rearrangements during channel transition to the open state. Since then, the 
application of Anap to study ion channel structural rearrangements has expanded rapidly. In 
further VCF studies, Anap was incorporated in the intra-cellular catalytic domain of CiVSP to 
monitor its voltage-dependent rearrangements [59], as well as in the extra-cellular and 
transmembrane domains of glycine receptors to study the mechanisms of partial agonism 
[60]. The versatility of UAA site insertion, in particular intra-cellularly, was further exploited to 
monitor the structural rearrangements during gating of key intra-cellular regulatory domains 
of cyclic nucleotide-gated (CNG) [54], TRPV1 [56] and EAG-like (ELK) voltage-gated 
potassium channels [55]. 
 In summary, the main advantage of genetic fUAA incorporation compared to post-
translational labeling lies in their unrivaled site tolerance. Furthermore, due to their compact 
structures, fUAAs like Anap are more tightly associated to the protein than tethered 
fluorophores. Therefore, they allow more accurate distance measurements in FRET 
experiments and are likely to sense subtle conformational changes that would be averaged 
out by organic tethered fluorophores, which are often connected to the protein via a flexible 
linker [57]. However, the small size of fUAAs is also a disadvantage. They are usually excited 
by UV-range wavelengths (360 nm for Anap in water [52]) that induce strong auto-
fluorescence from the cell cytoplasm. Moreover, they have an extinction coefficient (ɛ) and 
quantum yield (Q) lower than most common organic fluorophores (ɛ = 19500 cm-1M-1, 
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 9 
Q = 0.22 in aqueous buffer for Anap [56] vs ɛ = 93000 cm-1M-1; Q = 0.79 in PBS for 
AlexaFluor® 456). Considering that proteins incorporating fUAAs are usually expressed at 
lower levels than their wild-type or cysteine-mutated counterparts, the use of fUAAs may lead 
to a lower fluorescence signal-to-noise ratio. Examples in the literature show, nevertheless, 
that it is possible to obtain similar levels of fluorescence changes with Anap or tethered 
fluorophores (Figure 2D, also compare refs [60] and [61]), likely because the strong 
environment sensitivity of this fUAA compensates for its poorer spectral properties. Anap can 
also yield fluorescence under two-photon excitation [62], raising the potential to study 
dynamics of ion channels in intact tissues. 
 
MANIPULATING ION CHANNEL FUNCTION USING LIGHT-SENSITIVE UAAs 
Decorating ion channels with light-responsive UAAs affords an artificial control mechanism 
that is orthogonal to the natural one provided by evolution (change in membrane potential, 
ligand binding). A variety of light-sensitive UAAs, carrying photo-crosslinking, photo-
switchable, photo-cleavable or photo-caged side-chains, have been successfully used to 
obtain remote and highly precise control of ion channel function. 
 Photo-chemical UAA decaging was initially performed in potassium channels and 
nAChRs expressed in Xenopus oocytes, using various protection groups attached to 
cysteine, glycine, or tyrosine [28, 63-65]. In a typical experiment, channel opening is 
hindered by the presence of the photo-caged UAA, carrying a photo-labile group (cage), 
which is removed upon illumination with wavelength-specific light. Although the recovered 
electrophysiological responses following photolysis were overall small, this initial work has 
provided first fundamental information about the kinetics of decaging. Recently, a photo-
activatable, inwardly rectifying potassium channel (PIRK), carrying the first genetically 
encoded photo-caged UAA, was designed [36]. The UAA 4,5-dimethoxy-2-nitrobenzyl-
cysteine (Cmn; Figure 3A,B), a photo-caged cysteine, was introduced into the pore of Kir2.1. 
When placed directly within the ion channel pore, the bulky UAA occluded it, keeping the 
channel in a non-conductive state (Figure 3A). Following expression in rat hippocampal 
neurons, brief UV pulses restored the outward potassium current, as detected by the 
suppression of neuronal firing. In this work, the authors also demonstrated the first 
expression and optical modulation of a light-sensitive UAA-containing ion channel in vivo. 
The UAA expression machinery was introduced by means of in utero electroporation and 
electrophysiological recordings were performed from acute embryonic mouse neocortex 
slices. The development of PIRK demonstrates a big achievement in the UAA world, opening 
new vistas in studying ion channel function in vivo. Since then, a photo-caged lysine was 
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successfully incorporated into a GFP-amber model protein in the mouse brain of live mice 
[33].  
 Another form of photo-chemical uncaging was further performed for photo-cleavable 
UAAs, which generate a ‘caged’ protein backbone that can be cut in two upon UV 
illumination [28]. Photolysis of the UAA 2-(nitrophenyl)glycine (Npg)  was utilized to induce 
peptide backbone cleavage in a loop of GABAA receptors, resulting in an alteration of their 
pharmacology [66]. Generally, the ability to modify the protein main chain using UAAs is a 
valuable tool for mechanistic investigations of ion channels [67]. The approach remains 
limited to cells amenable to direct UAA-tRNA injection however, since evolved 
tRNA/synthetase pairs for genetic encoding of the corresponding UAAs are still lacking. 
 To date, the most commonly used light-sensitive UAAs in the ion channel field are photo-
crosslinking probes. In particular, the two photo-crosslinkers Azido-phenylalanine (AzF) and 
Benzoyl-phenylalanine (BzF or Bpa) have been widely utilized for their potential to map 
protein-protein and protein-ligand interactions as well as their functional consequences [68]. 
Both UAAs are photo-chemically activated by light at the UV range, which generates radicals 
that covalently crosslink a C-H bond-containing chemical group in close vicinity (Figure 3C-
F) [69]. AzF and BzF can both be efficiently incorporated into proteins using specifically 
evolved AzF and BzF tRNA/synthetase pairs [70] that allow achieving robust levels of 
expression of various LGICs and VGICs in Xenopus oocytes and mammalian cells (as 
follows). 
 The power of BzF photo-crosslinking has been exploited to investigate if the VGIC 
KCNQ1 directly interacts with the -subunit KCNE1 [71]. Following BzF introduction into the 
auxiliary subunit, rapid and complete silencing of channel activity upon UV illumination was 
observed, indicative of covalent crosslinking to KCNQ1 (Figure 3C). Furthermore, BzF 
photo-crosslinking helped to clarify a variable stoichiometry model for the channel complex 
composition, a previously contentious issue. Taking advantage of light-induced crosslinking 
events in real time, subsequent work further investigated the dynamics of this interaction 
during the gating process, revealing a state-dependent interaction between KCNQ1 and 
KCNE1 [72]. These studies demonstrate the strong potency of genetically encoded photo-
crosslinkers to probe not only protein interactions directly in their cellular context, but also 
their dynamics during channel gating. 
 The powerful combination of light with the precise molecular control using photo-
crosslinking UAAs has further allowed capturing dynamic functional states underlying 
operation of iGluRs, ion channel receptors that mediate excitatory synaptic transmission in 
the brain. During their activation cycle, iGluRs pass through different short-lived conductance 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
 11 
states [73]. In particular, studying the ultrafast gating properties of AMPARs with activation 
rates of less than 1 ms calls for highly resolved spatio-temporal approaches [74]. The photo-
crosslinkers AzF or BzF were introduced at key intra- or inter-subunit interface sites within 
AMPA and NMDA receptors, positions that undergo pronounced conformational 
rearrangements during receptor gating. Following expression in either Xenopus oocytes or 
mammalian cell lines, photo-crosslinking was induced by UV stimulation and detected by 
simultaneous electrophysiological recordings. In AMPARs, by placing BzF between two 
adjacent agonist-binding domains (ABDs), applications of UV pulses promoted irreversible 
and potent inactivation of glutamate-activated responses in a state-dependent manner [75] 
(Figure 3E,F). Depending on the BzF position within the ABDs, receptor silencing was 
observed in either active, desensitized, or resting states, thus providing important information 
about inter-subunit rearrangements during gating transitions. In NMDARs, AzF photo-
crosslinking has been primarily used to study the N-terminal domains (NTDs), which lie the 
most distal to the transmembrane domain and display strong allosteric capacity [76]. By 
placing AzF at strategic locations at a NTD upper lobe dimer interface, both UV-induced 
potentiation and inhibition of channel activity were detected [35, 77], demonstrating the 
potential of this interface to mediate bi-directional control of NMDAR activity. AzF photo-
crosslinking of NTDs was performed in oocytes [77, 78], HEK cells, and primary hippocampal 
neurons [35], with consistent light-dependent effects. The design of light-sensitive AMPA and 
NMDA receptors has established a basis for using UAA photo-crosslinkers to study structure-
function mechanisms in large receptor complexes such as iGluRs. Recent work showing AzF 
incorporation into the GFP-amber model protein in generated transgenic Zebrafish and 
mouse lines further demonstrates the strong potential to use photo-crosslinking UAAs in vivo 
[40].  
 The irreversible nature of photo-crosslinking allows accumulation of ion channels or 
receptors trapped in the same state, resulting in strong biophysical phenotypes. Thus, 
physically trapped complexes can be isolated and confirmed biochemically [71, 75]. To 
obtain functional reversibility, as abundantly described when using PTLs, azobenzene-based 
photo-switchable UAAs (PSAAs) were developed [79]. PSAAs were recently implemented to 
generate a family of NMDARs that can be accurately and reversibly controlled by light 
(Figure 3G-I) [80]. PSAA introduction within different subunits and receptor domains enabled 
rapid, stable, and reproducible photo-control, achieved by light-dependent toggling between 
the trans and cis states of the azobenzene side-chain (Figure 3H). PSAA toggling within the 
receptor ABDs allowed control of co-agonist sensitivity, while targeting transmembrane pore 
sites enabled optical modulation of gating and permeation properties. Moreover, both 
subunit-specific and bi-directional (photo-inactivation and photo-potentiation) receptor control 
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were achieved [80]. PSAAs combine the powerful properties of UAAs and azobenzenes to 
reversibly manipulate ion channel function. Particularly, they can be incorporated at solvent-
inaccessible sites, thus providing new means to probe and directly control transmembrane 
domain motions with atomic scale definition. Some PSAAs contain additional functional 
groups (e.g. benzyl chloride) that allow formation of covalent bridges with adjacent cysteines 
in a light-dependent manner [79]. Future applications of photo-controllable bridge formations 
in ion channels that can combine reversibility (provided by the azobenzene moiety) and 
irreversibility (provided by cysteine-reactive groups) will allow more precise optical control, 
and potentially increase the mechanical forces exerted by the UAA to directly control channel 
gating. Enhanced biocompatibility is also to be expected with new PSAA versions harboring 
red-shifted azobenzene moieties [81]. 
 Taken together, light-sensitive UAAs offer great qualities as optopharmacological tools to 
study ion channel structural and functional properties at the molecular level, and crucially, in 
real time. When placed at key moving sites or interfaces, they provide valuable tools to 
address key questions regarding ion channel structure, gating, regulation, or assembly. 
Depending on the UAA of interest, channel activity can be either irreversibly turned on or 
turned off (e.g. photo-caged or photo-crosslinking UAAs), or be manipulated in a reversible 
manner (photo-switchable versions). So far, structure-function investigations and protein 
interaction studies have been primarily performed in oocytes or mammalian cell lines. 
However, first reports support the feasibility of UAA application in native preparations, 
opening new possibilities to study biological ion channel processes in a complex and 
preserved environment. 
 
IN VIVO USAGE OF UAAs: POTENTIAL AND CHALLENGES  
Optical manipulation of proteins such as ion channels in vivo is worthy of pursuit for obvious 
reasons. The accompanied gain of molecular control obtained by generating light-sensitive 
versions of entire ion channel families would greatly contribute to a deeper understanding of 
their physiological roles during normal and disease states, information highly valuable in drug 
design. With its site flexibility and genetic encodability, the UAA methodology provides highly 
precise and selective tools to dissect channel functionality at the sub-cellular, cellular, tissue, 
and model organism level. The existence of various UAAs carrying specific chemical groups 
offers a rich functional spectrum for light-mediated ion channel intervention, which can occur 
on a time scale compatible with their biological activity. Furthermore, incorporation of two 
different UAAs into the same ion channel (e.g. to unite distinct chemical properties) or even 
combination of different optopharmacological tools is conceivable [82]. 
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 Being multi-component tools, optogenetic pharmacology approaches are still technically 
demanding in regard of their use in native preparations. To apply the UAA methodology in 
vivo, essential requirements include (Table 2): (i) introduction and co-expression of genes 
encoding the mutant target and the tRNA/synthetase pair; (ii) administration of the UAA; and 
(iii) efficient delivery of light [11]. Although expression of the genetic components in 
mammalian cell lines or primary neuronal cultures following transient transfection has been 
proven efficient enough to obtain sufficient levels of mutant ion channels [34, 35], absolute 
expression yields are usually lower compared to their wild-type counterparts [34, 80]. Thus, 
delivery of the UAA expression machinery into multi-cellular systems poses challenges. Viral 
vectors have been used to include UAAs into proteins expressed in neural stem cells, 
primary neuronal cultures, organotypic brain slices, and even living mice [33, 37, 50]. In utero 
electroporation is an alternative [36]. Crucially, to ensure an adequate suppression of the 
amber codon, driven by efficient expression of a functional suppressor tRNA, multiple tRNA 
copies are required [33, 36, 41, 50]. In order to obtain maximal protein expression levels, the 
number of viral vectors should be kept low, preferably carrying several genes separated by 
IRES sequences [36, 50]. Favorably, by viral delivery, a high number of cells are infected, 
which can ideally deliver many copies of the tRNA/synthetase pair. High cell-type specificity, 
and thus very local modifications in signaling, can be obtained by characteristic vector 
design. Less beneficial, the over-expressed subunits co-exist with endogenous wild-type 
subunits, resulting in a mixture of ion channel populations. This can be avoided by the design 
of knock-in mice, where light-sensitive subunit versions substitute their wild-type counterparts 
to obtain ‘clean’ ion channel populations [22, 83]. Finally, the genetic code can be expanded 
and inherited following generation of transgenic mouse lines that directly incorporate the 
specific tRNA/synthetase pair into their genome [40, 41]. First, zebrafish and mouse strains 
allowing incorporation of the photocrosslinker AzF have become available [40]. Custom-
made transgenic mouse strains are, in theory, conceivable for any tRNA/synthetase pairs 
and should demonstrate a strong potential to study native ion channel function. 
 UAAs can be directly injected into the brains of living mice [33, 36], either solitary or in 
the format of dipeptides to increase delivery [36]. Alternatively, they can be supplied through 
drinking water or food with no described toxic side-effects [33, 40]. Depending on the tissue 
of interest, intraperitoneal injections can also be considered [41]. However, sufficient 
bioavailability of the UAA at the target tissue and cells may be an issue during long-lasting in 
vivo experiments. 
 To obtain maximal optical effects, an optimal light supply should be assured. Light 
should efficiently penetrate the tissue of interest without inducing damage, preferably by the 
use of longer wavelengths. Here, the obtained knowledge from utilizing PTLs is highly 
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valuable [22]. If it is inevitable to use short wavelengths in the UV range, light pulses should 
be applied in the shortest possible intervals, under consideration that intensity and duration 
of light can fine-tune channel modulation [36]. As for PTLs [84, 85], red-shifted UAA versions 
with enhanced light penetration and tissue tolerance will be of prime importance in vivo [81]. 
With respect to specificity, a number of potential limitations including ‘leakage’ through 
unspecific amber codon suppression [78, 86] or suppression of amber stop codons within 
other genes, are to be considered, but remain to be fully evaluated (Table 2). 
 In summary, although using UAAs is currently mostly performed in heterologous 
expression systems, these promising foregoing studies demonstrate that photo-modulating 
ion channel function in vivo is, despite obvious obstacles, within reach. Once resolved, 
genetic encodability, spatiotemporal accuracy, and molecular specificity should greatly 
contribute to our understanding of native LGICs and VGICs. 
 
CONCLUDING REMARKS AND FUTURE PERSPECTIVES 
UAAs can be efficiently introduced into ion channels to render them light-sensitive. To date, 
these ion channels can be robustly expressed in diverse cellular systems, tissues, and living 
animals. The nanoscale photo-control can either act as a biophysical probe, or a remote 
actuator of ion channel activity, thus providing novel insights into their gating properties, 
pharmacology, and interacting partners with excellent spatio-temporal precision. The broad 
applicability of light-sensitive UAAs in molecular engineering and cellular physiology 
emphasizes its significance in the fields of optogenetic pharmacology and optical monitoring 
of protein conformational changes. A wealth of structural and functional information can be 
gained using this technology in vitro on recombinant proteins, while, in vivo, it has the 
potential to address fundamental questions regarding native ion channel or receptor biology 
(see Outstanding Questions for examples). Next generation opto-chemical UAA tools will 
expand their functional repertoire and generate further light-sensitive ion channel families, 
whose activity will be fine-tuned without interfering with their natural activation. Given its 
broad utility and functionally rich implementation, UAA insertion is poised to become 
increasingly popular for investigating protein structure and function. 
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TABLE & FIGURE LEGENDS 
 
Table 1: Methodologies to confer light-sensitivity to an ion channel. 
 
Table 2: Overview of commonalities and differences between two light-sensitive 
probes – UAAs and PTLs. 
 
 
Figure 1: Genetically encoding light-sensitive UAAs into ion channels. 
The UAA genetic encoding methodology, as performed for mammalian cell lines, is 
represented schematically. (a) Vectors carrying genes for an ion channel of interest (light 
blue) and an orthogonal suppressor tRNA (orange) / aminoacyl synthetase (dark blue) pair 
are introduced into the cell by means of transient transfection. The amber stop codon (TAG, 
red) replaces a native codon at a permissive site within the sequence of the ion channel 
gene. (b) The light-sensitive UAA (purple asterisks) is supplemented into the cellular growth 
medium and spontaneously enters the cell, presumably through amino acid transporters 
(grey). (c) Within the cell, the orthogonal synthetase specifically aminoacylates the 
suppressor tRNA with the UAA, a catalytic reaction driven by ATP. (d) The UAA-carrying 
tRNA, which contains a CUA anticodon, enters the ribosomal machinery to incorporate the 
UAA in response to the complementary amber codon on the ion channel mRNA (black). (e) 
Once relieved from the charge at the ribosome, the tRNA can be reused for further UAA-
aminoacylation by the cognate synthetase. (f) The full-length polypeptide chain (here, 
exemplarily shown for two NMDAR subunits, PDB 4PE5 [87]; light blue), site-specifically 
carrying the UAA, undergoes folding and assembly into a functioning ion channel. (g) The 
newly formed membrane protein migrates to its assigned location (e.g. the cell surface) to 
selectively conduct ions (yellow), thus contributing to cellular functions. 
 
 
Figure 2: Fluorescent UAAs (fUAAs) to track ion channel structural dynamics. 
(A) Principle of VCF. An environment-sensitive fUAA (yellow asterisk) is genetically encoded 
at a specific location of an ion channel. Fluorescence of this UAA (blue thunderbolt) depends 
on the conformational state of the ion channel and can be correlated to the opening state of 
the channel through current measurements. (B) Chemical structures of fUAAs incorporated 
in ion channels using in vitro amino-acylated tRNAs. (C) Chemical structures of fUAAs, for 
which a bio-orthogonal tRNA/synthetase pair has been developed. (D) Motions of the intra- 
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and extra-cellular ends of the S4 segment, simultaneously recorded with gating currents 
(induced by S4 motion) in Shaker [57]. Upper panel:  Schematic representation of Shaker. 
Only two of the four subunits are represented. In ref [57], Anap (red star) was introduced at 
the intra-cellular end of S1 (V234), close to S4, while a cysteine in the S3-S4 loop (A359) 
was labeled with TMR (green asterisks). Lower panel:  Gating currents (I) and fluorescence 
responses (FAnap and FTMR) of TMR-labeled Shaker-V234Anap-A359C channels. From ref 
[57]. 
 
 
Figure 3: Examples of optical ion channel modulation by light-sensitive UAAs. 
Ion channels are illustrated in blue. (A) Incorporation of a caged UAA (5-branch asterisk), 
here a caged cysteine, in the pore of a VGIC (e.g. PIRK [36]) hinders the conductance of 
ions (yellow). UAA photolysis by UV light (purple thunderbolt) releases the cage (8-branch 
asterisk) and restores current flow. (B) Chemical reaction of Cmn photolysis. (C) UV-induced 
photo-crosslinking of a VGIC to an auxiliary subunit (green). (D) Chemical reactions of the 
covalent photo-crosslinking by BzF and AzF following UV illumination. (E) Photo-inactivation 
by intra-receptor UV-crosslinking of a LGIC (e.g. an iGluR). Photo-crosslinking UAAs, placed 
at key moving interface sites, physically link adjacent subunits. (F) Left, representative time 
course of inactivation of the homomeric GluA2 AMPA receptor (with BzF at the S729 site), 
induced by photo-crosslinking of subunits, following application of UV pulses (violet bars) of 
different durations (red and green circles). Right, example traces recorded before (black) and 
at the end (red and green) of the two UV protocols of the left panel, highlighting UV-mediated 
receptor silencing. From ref [75]. (G) Reversible photo-modulation of ion channel activity. 
Photo-switchable UAAs, placed at key modulatory sites, can rapidly turn on or turn off 
receptor activity by toggling between a cis (purple asterisk) and a trans configuration (blue 
asterisk), induced by UV and blue/green range wavelengths (purple and blue thunderbolts), 
respectively. (H) Chemical structures of the cis and trans photoisomers of PSAA, a photo-
switchable UAA. (I) Representative current trace of GluN1/GluN2A NMDARs carrying PSAA 
at GluN1-P532 under illumination by UV and blue light, demonstrating reversible photo-
modulation. From ref [80].  
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BOX 1 
COOKBOOK: ENGINEERING LIGHT-SENSITIVE ION CHANNELS IN MAMMALIAN CELL 
LINES 
 
Overall, genetically encoded UAAs can be introduced into any ion channel of interest, if 
certain technical and strategic proceedings are respected. Most of the mentioned light-
sensitive UAAs can be obtained commercially and their corresponding tRNA/synthetase 
pairs are usually available on request from groups, who have evolved those.  
 The introduction of UAAs calls for high-level molecular precision. Hence, protein 
engineering using UAAs benefits from existing structural and molecular information, 
facilitating technical processes including mutagenesis, experimental design, and data 
interpretation. Prior investigating novel, poorly resolved domains, introduce the UAA at well 
characterized ion channel regulatory sites to gain first broad ideas about the efficiency of 
UAA incorporation, the resulting ion channel functional properties, and their behavior 
following optical modulation. Generally, incorporating UAAs in large proteins such as ion 
channels involves a screening process to identify strong candidate positions, assigned by 
minor functional side-effects following UAA introduction per se (ion channel carrying UAAs 
should desirably show wild-type-like biophysical properties) and major functional impacts 
upon light-stimulation. Indeed, even if UAAs produce only minor structural perturbations, 
since only one side-chain within the polypeptide sequence is altered, these are not always 
subtle. Light-sensitive UAAs, usually of aromatic nature, are bulkier in size compared to 
natural amino acids and may therefore induce significant perturbation of channel function 
that could interfere with the optically induced effects. Furthermore, since photo-modulation 
measurements often require long-lasting recordings, the UAA has to be stable within the 
protein, with no unspecific side-effects in the absence of light, as for example observed for 
AzF [80, 88]. 
 Usually, the degree of photo-effects depends on the duration and intensity of light, with 
faster photo-modulation rates following longer and stronger illumination (see, for example, ref 
[80]). To ensure that the maximal photo-effect is obtained, use a strong source of light, such 
as high-power LEDs, at a precise illumination wavelength in accordance to the UAA 
absorbance spectrum. 
 Importantly, verify that truncated ion channel versions, due to a premature termination of 
protein translation or a shift of its initiation [78, 86], do not interfere with the function of full-
length ion channels or even induce false-positive effects. Also, evaluate the degree of 
unspecific read-through by endogenous amino acids, which can be significant, in a 
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standardized manner by control experiments in the absence of the UAA (see, for instance, 
ref [78]; discussed in ref [89]). Lastly, consider the multimeric nature of ion channels in the 
interpretation of results. Depending on the subunit composition, an ion channel may contain 
multiple UAA copies, thus potentially producing complex photo-effects upon light-stimulation. 
Particularly, this is important when determining the kinetics of the photo-effects.  
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GLOSSARY  
 
Azobenzene moiety: Azobenzene moieties undergo reversible toggling between two photo-
isomerizable states in dependence of light illumination – a compact cis- (usually upon 
exposure to UV light) and a stretched trans-configuration (upon application of light in the 
blue/green range). The absorbance spectrum is variable in dependence of adjoined chemical 
modifications. Because of their synthetic tractability, high quantum yield, stability, and 
biocompatibility, azobenzene moieties are currently the most commonly used photo-
switches.  
 
Bio-orthogonality: Specifically engineered tRNA/synthetase pairs must be bio-orthogonal to 
avoid crosstalk with the native biosynthetic machinery. An orthogonal tRNA must not be 
aminoacylated by any endogenous tRNA-synthetase and an orthogonal synthetase must not 
aminoacylate any endogenous tRNA with endogenous amino acids. When incorporating 
UAAs, bio-orthogonality can be checked using proper control experiments. 
 
FRET: Förster Resonance Energy Transfer is a highly sensitive technique that allows the 
transfer of energy between two chromophores, a donor and an acceptor. The efficiency of 
energy transfer depends on the distance and orientation between the two chromophores. 
FRET measurements are therefore powerful tools to study distance changes between two 
domains in real time, as occurs during ion channel gating. 
 
Genetic code expansion: Genetic code expansion allows introducing amino acids 
(unnatural amino acids, UAAs) that are not specified by the standard genetic code. Site-
specific incorporation of UAAs into proteins expressed in living cells occurs by suppression of 
nonsense codons (stop codons) by UAA-aminoacylated tRNAs. Traditionally, amber (TAG) 
stop codons are used. Efficient suppression of an amber codon results in a functional full-
length protein. UAAs carry side-chains with diverse physicochemical properties, not available 
in the 20 natural amino acids, thus adding novel functionalities into proteins. They can be 
introduced in any kind of protein, regardless of its type, size, or location.  
 
VCF: Voltage-clamp fluorometry is a technique to simultaneously measure ion channel 
electrical activity through electrophysiology and monitor local molecular rearrangements 
through spectroscopic approaches such as fluorescence quenching or FRET. VCF based on 
fluorescence relies on the sensitivity of specific fluorophores to the chemical properties of 
their local environment (polarity and presence of endogenous quenching groups). 
Conformational rearrangements, such as during ion channel gating, provoke changes in the 
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environment of the fluorophore, thus instantaneously changing its emission spectrum or 
fluorescence quantum yield. VCF is a powerful method to correlate ion channel structure and 
function in real-time. 
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OUTSTANDING QUESTIONS 
 Studying ion channels in vivo is essential for understanding their physiological and 
pathological roles. Transgenic animals with an expanded genetic code open possibilities 
to manipulate specific ion channel populations in whole tissues or organisms. Challenges 
to address are numerous. For example, can chronic UAA delivery be achieved? How 
prominent are off-target UAA effects? Can ‘faulty’ ion channel subunits, including 
truncated versions or those carrying endogenous amino acids instead of the UAA, be 
minimized? 
 fUAAs are powerful tools to investigate structural mechanisms of recombinant ion 
channels. Whether this technology can be expanded to more native situations remains 
unclear. fUAAs in vivo have the potential to inform on how the cell microenvironment 
influences channel gating and what the underlying mechanisms are. For enhanced 
biocompatibility, genetically encoded fUAAs with better spectral properties (such as 
stimulation by red-shifted wavelengths) are needed. 
 The occurrence of specific ion channel subpopulations is dynamic, depending on the 
tissue, cell type, developmental stage, and subcellular location. At a given time and 
location, what is the ion channel diversity landscape and how is it dynamically regulated? 
Optogenetic pharmacology provides new means to address these questions with 
unprecedented precision. 
 UAAs can in principle be inserted anywhere in the protein, allowing control of channel 
activity at multiple channel locations. Introducing light-sensitive UAAs in cytoplasmic 
regions of an ion channel should help interrogate how it interacts with intracellular 
partners and how dynamic these interactions are. 
 The vast investigation of ion channels and their interacting partners in their native 
environment is essential to define biological targets in drug design. Defining novel and 
potent medication strategies that reach beyond the structural level of proteins could be 
key to treat diseases linked to dysfunction in ion channel signaling. 
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LIGHT-SENSITIVE UAAs
(i) genetically modified ion channel (amber mutation)
(ii) genes for tRNA/synthetase pair
(iii) UAA or UAA-dipeptide of choice
During protein biosynthesis (addition of UAA into the
growth medium or cellular injection)
In theory, 100% (but see below for the ‘leakage’ issue)
Small: single photo-reactive side-chain of aromatic
nature
Lower: limited by the co-evolution of a bio-orthogonal
tRNA/synthetase pair
In principle, ‘absolute’ (only minor steric restrictions)
Usually in the UV range; red-shifted photo-switching
UAAs are under development
Constant turn-over of the tRNA; supply of the UAA
may be limiting
Unknown
• Premature stop at amber codon      truncated
  subunits
• ‘Leakage’, i.e. unspecific read-through at the 
  introduced amber codon      ion channels carrying
  endogenous amino acids
• Incorporation of UAAs at natural amber codons
        modifications of the proteome
PHOTO-SENSITIVE TETHERED LIGANDS (PTLs)
(i) genetically modified ion channel (cysteine mutation)
(ii) PTL of choice
(iii) reducing agents if necessary
Post-translational extra-cellular labeling
<100%       mixed populations with ‘non-labeled’ 
channels
Bulkier multi-component molecule; easily adjustable in
length
High: only limited by the feasibility of the PTL chemical
synthesis
Only extra-cellular, solvent-accessible regions
Cis-isoform: 360-400 nm (UV range), trans-isoform:
460-560 nm (blue/green range) or darkness; red-shifted
versions available
Re-labeling required
Tens of minutes
• Unspecific cysteine conjugation      PTLs at false
  ion channel positions or within other proteins
• in vivo, off-target effects of PTLs acting as 
  soluble ligands on other proteins
POSSIBLE SIDE- AND OFF-
TARGET EFFECTS
TIME WINDOW IN VIVO
SUSTAINABILITY
LIGHT PROPERTIES
VERSATILITY OF SITE
INSERTION
BIOCHEMICAL DIVERSITY
MOLECULAR SIZE
EFFICIENCY OF
INCORPORATION
MODE OF INTRODUCTION
MOLECULAR
COMPONENTS
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TRENDS 
 
 Optopharmacological approaches allow to engineer light-sensitivity into ion 
channels that are naturally not responsive to optical stimulation. 
 
 Genetically-encoded light-sensitive unnatural amino acids (UAAs) as single side-
chain probes provide direct and highly precise optical control over ion channel 
function. 
 
 Recent fluorescent UAA probes with high environmental sensitivity can accurately 
track ion channel conformational rearrangements. 
 
 Photo-cleavable, photo-caged, photo-crosslinking and photo-switchable UAAs 
allow real-time optical control over ion channel structure, gating, pharmacology, and 
interaction with auxiliary proteins. 
 
 Recent advances of utilizing UAAs in vivo opens up new vistas to study biological 
ion channel processes in interrelation to their native environment. 
 
 
 
 
Highlights
